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Abstract
Background: Achilles tendinopathies are common among individuals who are active, usually
participating in a sport with a high volume of repetitive motion. Historically, these injuries have
been treated with conservative home exercises. If the patient exhausts their conservative
treatment options, the next step is typically surgery to repair the tendon (Maffulli, 2015).
Recently, platelet-rich plasma (PRP) injections have become more commonly used to treat
musculoskeletal injuries and are considered minimally invasive procedures. This allows the
patient to return home immediately post injection and return to activity within a few days.
However, the research shows mixed results in terms of its effectiveness for treating these
conditions.
Purpose: Determine whether platelet rich plasma (PRP) injections are an effective treatment
option for individuals diagnosed with Achilles tendinopathy.
Results: Sixteen scholarly articles were analyzed using a matrix format and were evaluated with
The John Hopkins Nursing Evidence-Based Practice appraisal tool. Eight of the 16 articles were
in favor of using PRP injections to treat Achilles tendinopathies. This was determined using the
VISA-A as the primary outcome measure while return to function, tendon thickness and
vascularity were common secondary outcomes. Five articles reported PRP injections were not an
effective treatment option; three articles concluded they required larger scale studies to make a
determination.
Conclusion: PRP injections can be used secondary to traditional treatment of eccentric exercise
and other modalities for patients who are looking for a minimally invasive treatment option.
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Implications for Research and Practice: The findings of this research does not outline a clear
determination for whether or not PRP injections are an effective treatment option for participants
diagnosed with Achilles tendinopathy. Further research is needed on “excellent” quality articles
with larger numbers of participants and with standardization of the preparation/procedure of the
PRP injection.
Keywords: Achilles tendinopathy, platelet-rich plasma, PRP, treatment
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Chapter Ⅰ: Introduction
Over the last few years, platelet rich plasma (PRP) injections have become more
commonly used to treat musculoskeletal injuries. United States estimates alone suggest that
approximately 86,000 athletes are treated with PRP annually (Wasterlain, 2013). PRP has been
used to treat a wide variety of orthopedic conditions, including knee osteoarthritis, lateral and
medial epicondylitis, rotator cuff repair, patellar and Achilles tendinopathy, hamstring injuries,
and anterior cruciate ligament (ACL) repairs. The research has shown mixed results in terms of
its effectiveness for treating these conditions. PRP injections are a form of regenerative
medicine. Doctors and researchers have found that the body has the ability to repair itself.
Plasma is the liquid portion of the blood and is made up of mostly water and proteins. Platelets
are the blood cells in the body that cause blood clots as well as necessary growth healing
functions (Wasterlain, 2013). PRP therapy utilizes injections that use the patient’s own platelets
to accelerate healing in the body. The injection process is started by taking a few tubes of blood
from the patient and putting them in the centrifuge to separate and concentrate the platelets. The
physician then takes those platelets and injects them back into the patient at the injured site. This
releases growth factors that stimulate and increase the number of reparative cells your body
produces (Wasterlain, 2013). While research is still limited, there has been debate on whether or
not PRP injections are an effective treatment option for Achilles tendinopathy injuries. Some
research has shown there are minimal to no benefits, while others state this is a viable treatment
option for patients.
Achilles tendinopathy, an overuse injury that occurs from repetitive and intense strain on
the Achilles tendon has a prevalence of 9-40% in active individuals (Ackermann, 2012). This
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variation is due to the type of activity the individual participates in and the activity level of the
individual. Individuals suffering from Achilles tendinopathy will typically have a mild ache in
the back of their leg or above their heel after activity. They might also experience tenderness and
stiffness either right away in the morning or after long bouts of inactivity.
The traditional treatment for individuals diagnosed with Achilles tendinopathy is
eccentric exercises (O’Neill, 2015). These exercises are stretching and strengthening exercises to
target the Achilles tendon and the surrounding structures. Eccentric exercise involves a slow
elongation of the muscle after a shortening contraction. The most common Achilles tendon
eccentric exercise is to have the individual stand on the edge of a stair/ledge rise up on their toes,
and then have them slowly lower themselves down, lowering themselves past the point of their
toes. This eccentric exercise assists in lengthening the muscle; once the muscle has reached its
end range, the lengthening ceases and the tendon undergoes a stretching period prior to a
shortening period (O’Neill, 2015). It is critical to the patient's care to effectively manage their
Achilles tendinopathy. After six months of conservative treatment, if there is no clinical
improvement the next recommendation is surgical intervention (Maffulli, 2015). However,
without some management of the injury, roughly 4% of individuals diagnosed with Achilles
tendinopathy end up rupturing the tendon (Yasui, 2017). This could lead to a much longer
timeframe when the patient would return to normal function.
Statement of Purpose
The purpose of this study is to determine whether platelet rich plasma (PRP) injections
are an effective treatment option for individuals diagnosed with chronic Achilles tendinopathy.
To determine the effectiveness of treatment options, outcomes assessed will be pain levels and

8
the amount of time to return to pre-injury level function. Minimal research has been conducted
on the effects of PRP injections on Achilles tendinopathy injuries. This could be inhibiting PRP
from becoming more widely used in orthopedic practices and could also be deterring insurance
companies from seeing the benefits of this treatment option in order to cover the cost of services
for patients.
Need for Review
Achilles tendinopathies are common among individuals who are active, usually
participating in a sport with a high volume of repetitive motion. Historically, these injuries have
been treated with conservative home exercises. If the patient exhausts their conservative
treatment options, the next step is typically surgery to repair the tendon (Maffulli, 2015). PRP
offers another form of conservative treatment that could potentially decrease pain levels as well
as return patients to pre-injury function sooner than a patient’s at-home exercise program. PRP
injections are considered a minimally invasive procedure, which allows the patient to return
home almost immediately post injection and return to activity within a few days. The injected
substance is coming directly from the patient’s body, which reduces the risk of the body having
adverse side effects from an unknown substance being injected. Platelets from the blood, once
they are injected into the body, offer healing and reduce inflammation at the injection site. This
allows for the patients to be taken off of their anti-inflammatory medications. Long term use of
anti inflammatory medication can have adverse health risks. It can cause gastrointestinal
bleeding (bleeding in the stomach or elsewhere in the digestive tract), increases the risk of heart
attack or stroke, skin reactions such as skin reddening, rash or blisters, or allergic reactions such
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as hives, facial swelling, and wheezing (Commissioner, 2015). PRP injections are a more natural
way for a muscle, tendon, ligament or joint to begin healing itself.
It is also necessary to review PRP injections in terms of whether or not it is cost effective
for the patient. Currently, insurance companies have not seen adequate research stating that PRP
injections are effective treatment options. Patients typically will have to pay for these injections
out of pocket. This poses the question of whether or not the PRP injections are cost effective
when compared to the traditional eccentric home exercise program. Another aspect to consider is
the frequency with which patients would need these injections. If the patient is able to have one
injection and return to function and then manage their symptoms moving forward, it is
potentially a cost-effective treatment. However, if the patient needs to return to the clinic for an
injection every 6-9 months, the treatment might not be right for them financially. If the PRP
injection is going to reduce recovery time and return people back to function in a timely manner,
then the out of pocket cost might be worth it for patients in the long run, and/or insurance
companies will see the benefits and begin covering these services.
Significance for Athletic Training
An Athletic Trainer (AT) is an individual who works directly under a supervising
physician. They respond to a wide variety of injuries in a multitude of different settings. ATs are
well educated in the diagnosis and treatment of musculoskeletal injuries, and in some instances,
they are the first people to lay eyes on the injury. An Athletic Trainer’s main goals are to
effectively and efficiently diagnose an injury and provide the best individualized treatment for
the patient/athlete to return to function (Athletic Training, Minn. Stat, 2020). In order for an AT
to provide the best care for their patients, they need to understand the benefits and risks of the
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treatment plans they are recommending. It’s necessary that an AT continue to learn, grow, and
adapt with the new techniques of the medical world. However, PRP can take up to 3 months for
the effects to take place in the body (Finnoff, 2011). In some instances, PRP injection might not
be the most time- effective solution for a patient to return to activity. Athletic trainers need to be
able to understand the pros and cons of each available treatment option and help their patients
make the best decision for them individually. Overall, this review is intended to provide an
understanding for ATs as to what treatment is best for their patients to reduce their pain levels
and return them to function as quickly as possible after they have been diagnosed with Achilles
tendinopathy.
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Chapter Ⅱ: Methods
This chapter describes the processes and methods used to examine articles on the
effectiveness of platelet-rich plasma (PRP) injections and eccentric exercise for the treatment of
individuals diagnosed with Achilles tendinopathy. The search strategies, inclusion and exclusion
criteria, number and type of studies selected, as well as the criteria used for evaluating the studies
are discussed in this chapter.
Search Strategies
The majority of the studies found for this Critical Review of the Literature came from
using CLICSearch, a database available to members of the Bethel University community. Several
other articles were found using PubMed and Scopus. The remainder of the studies were found
using the references of previously listed studies with a similar topic of study. Using the
CLICSearch, the initial keyword used was “achilles tendinopathy.” This yielded over 6,000
results. In order to narrow the search, I included the keywords, “PRP or platelet-rich plasma,”
which lowered the results to 1,100. In order to compare platelet-rich plasma injections and
eccentric exercise for the treatment of achilles tendinopathy, the search team “eccentric exercise”
was included; this yielded 368 results. CLICSearch allows for the researcher to set certain
parameters for the search. The parameter of “peer reviewed” was selected to eliminate as much
bias in the articles as possible. The initial search also included only “open access” articles to gain
a starting point for the search process. This brought the article count to 132. By changing the
dates to include only articles from 2010-2019, only 112 results remained. Lastly, the parameter
“humans” was selected, and the parameter “surgery” was excluded. This left 31 remaining
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results. The next step was to exclude articles that were irrelevant to the topic. Eighteen articles
were used in this Critical Review of Literature.
Inclusion and Exclusion Criteria
Inclusion and exclusion criteria were determined to locate relevant articles that were
recently published in the Critical Review of Literature. In order for an article to be included, it
had to have platelet-rich plasma injections and/or eccentric exercise as the treatment of Achilles
tendinopathy. The articles also had to have been published within the last decade. All populations
were included in this study, specifically all active and inactive individuals. All study designs
were considered when reviewing the literature.
Exclusion criteria eliminated articles that were published prior to 2010. Articles that used
treatment methods other than platelet-rich plasma injections and/or eccentric exercise for the
treatment of Achilles tendinopathy were excluded. Articles with subjects who had ruptured their
Achilles tendon (partially or fully) were also excluded. If the articles were not available other
than to purchase or they were in another language other than English, they were excluded from
this Critical Review of Literature as well.
Number and Types of Articles
Based on the inclusion and exclusion criteria, sixteen articles were chosen. All of the
articles were reviewed using the John Hopkins Nursing Appraisal tool. See Appendix B.
The John Hopkins Nursing Evidence-Based Practice appraisal tool was used to determine the
quality of each article; the articles were given a score of “High quality,” “Good quality,” or “Fair
quality or major flaws.” This appraisal tool clearly explains how to deem the quality of the study.
A high-quality study was characterized as being “consistent, generalizable results; sufficient
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sample size for the study design; adequate control; definitive conclusions; consistent
recommendations based on comprehensive literature review that includes thorough reference to
scientific evidence” (Dearholt, 2012). There was only one “high quality article.” A good quality
study was characterized as being “reasonably consistent results, sufficient sample size for the
study design; some control; and fairly definitive conclusions; reasonably consistent
recommendations based on fairly comprehensive literature review that includes come reference
to scientific evidence” (Dearholt, 2012). There were thirteen “good quality” articles. Lastly, the
fair-quality study was characterized as being “little evidence with inconsistent results;
insufficient sample size for the study design; conclusions cannot be drawn” (Dearholt, 2012).
There were four “fair quality” articles. The level of evidence for each study was also assessed
using the John Hopkins Nursing Evidence-Based Practice appraisal tool. The appraisal tool
categorized the studies into two sections: A-Single Research Studies and B-Systematic Reviews
with or without Meta-Analysis. In part A, three questions were answered:
Question 1: Was there manipulation of an independent variable?
Question 2: Was there a control group?
Question 3: Were the study participants randomly assigned to the intervention and control group?
Based on the answers to those questions, the articles were assigned a level. If “yes” was
answered for all three questions, the study was considered a randomized control trial (RCT or an
experimental study and determined to be a level 1). If “yes” was answered to questions 1 and 2
but “no” was answered to question 3, the study was considered quasi-experimental and given a
level 2 grading. Lastly, if “no” was answered to questions 1, 2, and 3, the study was considered
non-experimental and given a level 3 grade. In part B, if all the studies were Randomized
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Controlled Trials (RCT), they were deemed level 1. If the articles were a combination of RCTs
and quasi-experimental, or quasi-experimental only, the article was deemed level 2. Lastly, if the
articles were a combination of RCTs, quasi-experimental, and nonexperimental or
non-experimental only the article was deemed a level 3. Table 1 provides a clear representation
of the level of evidence and quality for each article included in the literature review.

Table 1: Level of Evidence and Quality of Included Articles
Level of Evidence

I

High

Good

Fair

Total Number of

Quality

Quality

Quality

Articles

1

6

2

9

II

4

III

4
3

Total

3
16

Criteria for Evaluating the Studies
Each included study was placed into a matrix developed by the Bethel University
Graduate Nursing Program. The information integrated in the matrix included citation, design
methodology, purpose, sample/setting, design instruments, results and recommendations. In the
sample/setting column, subheadings were included to incorporate the “level of evidence” and
“quality of the article.” The “level of evidence” and the “quality of the article” were, as stated
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above, assessed using the John Hopkins Nursing Evidence-Based appraisal tool. The “Hierarchy
of Evidence for Intervention Studies” chart categorizes the levels by research type. The lower
numbers on the chart (one or two) are considered to be better quality studies than articles that fall
into the four or five categories (Fineout-Overholt et al., 2010). A study is deemed “high quality”
if they are able to correlate their findings to another high-quality study, obtain an adequate
sample size, have a control group, and are able to blind their participants to the treatment in
question. A fair-quality study typically has a small sample size, no control group and is unable to
collaborate their findings with other researchers’ studies.
Summary
Multiple databases were used to research articles using platelet-rich plasma and/or
eccentric exercise as an intervention for the treatment of Achilles tendinopathy. In total, sixteen
articles were found once inclusion and exclusion criteria were established. Once the articles were
identified, the level of evidence and level of quality were reported on each article.
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Chapter III: Literature Review and Analysis
Synthesis of Matrix
In this chapter, the 16 current scholarly articles will be reviewed and analyzed. The aim
of this chapter is to use these scholarly articles to answer the research question that was
presented in chapter one. The Bethel University Graduate Nursing Program matrix was used to
accomplish this goal. The matrix is a chart that aids in the organization of the articles found for
the review. The articles were divided and categorized according to their level of evident as
determined by the John Hopkins Nursing Evidence-Based Practice appraisal tool. The appraisal
tool categorizes the studies into two sections: A-Single Research Studies and B-Systematic
Reviews with or without Meta-Analysis. In section A, studies represented are randomized
control trials, quasi experimental, retrospective case studies, or pilot studies. In section B, studies
represented are systematic reviews, and meta-analyses. This information was also documented in
the matrix. In each section, A and B, there were three different levels of evidence, Ⅰ, Ⅱ, and
Ⅲ. Articles are presented in order of their level of evidence and summarized alphabetically
according to the authors’ last names. The matrix and analyzed information can be located in
Appendix A.
Synthesis of Major Findings
Level Ⅰ Evidence: Based on the Johns Hopkins Nursing Evidence-Based Practice
appraisal tool, there are nine articles that fell into the category of Level Ⅰ evidence. These are a
combination of articles from sections A and B of the appraisal tool used. The articles are
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summarized below starting with articles in section A with Level Ⅰ evidence, and moving to
articles in section B with Level Ⅰ evidence.
Section A:
Boesen, A., Hansen, R., Boesen, M., Malliaras, P., & Langberg, H (2017) conducted a
RCT to determine whether eccentric training in combination with high-volume injection (HVI)
or platelet-rich plasma (PRP) injections improved outcomes in Achilles tendinopathy. The study
included 60 men between the ages of 18 and 59 who had chronic Achilles tendinopathy (>3
months) and followed them for six months. All of the subjects participated in eccentric exercise
training with a combination of (1) one HVI injection of steroid, saline, or local anesthetic, (2)
four PRP injections each 14 days apart, or (3) placebo (a few drops of saline under the skin).
Outcomes assessed were function, symptoms using the Victorian Institute of Sport
Assessment-Achilles Questionnaire (VISA-A), tendon thickness and intratendinous vascularity
(ultrasonographic imaging and Doppler signal), and muscle function (heel-rise test). The results
showed treatment with HVI or PRP in combination with eccentric training in chronic Achilles
tendinopathy seems more effective in reducing pain, improving activity level, and reducing
tendon thickness and intratendinous vascularity than eccentric training alone. HVI may be more
effective in improving outcomes of chronic Achilles tendinopathy than PRP in the short term.
This study recommended a larger sample size and a determination of the exact concentration of
platelets and growth factors in the PRP injections.
De Vos, Weir and Van Schie (2010) conducted a RCT to examine whether a PRP
injection would improve outcome in chronic midportion Achilles tendinopathy. The study was a
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randomized, double-blind study in which 54 participants with chronic Achilles tendinopathy
participated. All participants went through eccentric exercise with either a PRP or saline
injection. There were 27 subjects in each group with complete follow up. The VISA-A
questionnaire was used to evaluate pain and activity levels; this was measured at week 6, 12 and
24. The results showed the mean VISA-A score improved significantly after 24 weeks in the
PRP group by 21.7 points and in the placebo group by 20.5 points. This was not statistically
significant. The conclusion of this study was that patients with chronic Achilles tendinopathy
who were treated with eccentric exercises and a PRP injection compared with a saline injection
did not result in greater improvement in pain and activity. The study had no specific
recommendations for further follow up.
One year later, Jonge, de Vos, and Weir did a follow up on the RCT they performed in
2010. (2011). The aim of their study was to determine the effects of the PRP injection one year
post injection. All 54 participants followed up at the one year mark. The primary outcome was
the Victorian Institute of Sports Assessment–Achilles (VISA-A) score. Other outcome measures
were subjective patient satisfaction (scored as poor, moderate, good, or excellent) and return to
sports activity (scored as not active in sports, no return to sports, returning to sport but not in
desired sport, returning to desired sport but not at the preinjury level, or returning to preinjury
level in the desired sport). Tendon structure was evaluated quantitatively by means of UTC
(UTCimaging). Neovascularization was scored using the modified O¨ hberg scoring system. The
mean Victorian Institute of Sports Assessment–Achilles score improved in both the platelet-rich
plasma group and the placebo group after one year. There was no significant difference in
increase between groups. In both groups, 59% of the patients were satisfied with the received
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treatment (Jonge et al. 2012). Ultrasonographic tendon structure improved significantly in both
groups but was not significantly different between groups. The study concluded that there was no
superiority of the PRP injection when compared to the saline injection in chronic Achilles
tendinopathy at the one year mark when accompanied by eccentric exercise training. There were
no formal recommendations by the authors of this study.
Kearney and Parson (2013) conducted a pilot RCT to evaluate the feasibility of
conducting a larger trial to evaluate the difference in VISA-A scores at six months between
patients with Achilles tendinopathy treated with a PRP injection compared with an eccentric
loading programme. Two groups of patients with midsubstance Achilles tendinopathy were
randomised to receive a PRP injection or an eccentric loading programme. A total of 20 patients
were randomised, with a mean age of 49 years (35 to 66). The VISA-A was the primary outcome
measure and was recorded at baseline, six weeks, three months and six months. The mean
VISA-A score for the injection group at the primary endpoint of six months was 76.0 and for the
exercise group was 57.4. There was no statistically significant difference between these scores.
The conclusion of this study was that it had the ability to conduct a larger scale study to
determine the effectiveness of PRP injections when treating Achilles tendinopathy. The results
did not reflect any significant findings, but a larger scale study should be done to provide more
clarity.
Krogh (2016) performed a RCT with the purpose of examining whether one injection of
PRP would improve outcomes more effectively than placebo (saline) after 3 months in patients
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with Achilles tendinopathy (AT). A total of 24 participants were randomized into the PRP
injection group or the saline (placebo) group. The primary endpoint was improvement in
VISA-Ascore at 3 months. Secondary outcomes were pain at rest, pain while walking, pain when
the tendon was squeezed, ultrasonographic changes in tendon thickness, and color Doppler
activity. The results showed the PRP injection did not result in an improved VISA-A score over
a 3-month period in patients with chronic AT compared with placebo. The only secondary
outcome demonstrating a statistically significant difference between the groups was change in
tendon thickness; this difference indicates that a PRP injection could increase tendon thickness
compared with saline injection. The conclusions are limited to the three months after treatment
due to the large dropout rate of this study. The recommendation of this study is that a larger
sample size be used, and performed on individuals who are not in such a late stage of
tendinopathy.
Section B:
Liu et al. (2019) completed a meta-analysis evaluating the current evidence for the
efficacy of PRP as a treatment for chronic AT. They obtained all of their sources from PubMed,
Embase, Web of Science, and The Cochrane Library databases. Their aim was to find articles on
RCTs that compared the efficacy of PRP with that of placebo injections plus eccentric training as
treatment for chronic Achilles tendinopathy. The inclusion criteria was a diagnosis of Achilles
tendinopathy, an injection of PRP around the tendon, the VISA-A, visual analog scale (VAS),
must be a randomized controlled clinical trial and Achilles tendon thickness measurement. The
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exclusion criteria was PRP injection combined with surgical intervention, lack of non-PRP
controls, incomplete literature or duplicate literature. A total of 650 articles were obtained in the
initial search. After completing the screening using the inclusion and exclusion criteria, the
authors chose 5 RCTs to be used in this meta-analysis.
Liu et al. (2019) used the 5 RCTs that included 189 patients to complete this
meta-analysis. The VISA-A was the primary outcome indicator used for each of the RCTs. There
was no significant difference found in the improvement of the individuals when followed up with
at the 6, 12 and 24 weeks mark. However, the VISA-A score of the PRP group was significantly
higher than that of the control group 6 weeks after treatment. In two of the studies, patients were
followed up with at the one year mark. In those studies there was no significant difference
between the PRP and the placebo groups. The author concluded that PRP is a treatment option
for chronic Achilles tendinopathy, but in order to verify the results of this study, the authors
recommended a large number of well-designed, homogeneous RCT studies.
Madhi et al. (2020) conducted a systematic review to determine the efficacy of PRP as a
treatment option for individuals with chronic AT. . They obtained their articles using the
following electronic databases: PubMed, EMBASE, Cochrane collaborate, Google scholar, the
Web of Science and Cochrane Library. The quality of each study was evaluated using the Oxford
CEBM tool to assess the articles for validity, relevance, and applicability of the results. A total
number of 288 studies were found, and only 11 met the inclusion criteria. The inclusion criteria
was studies with designs of RCTs retrospective or prospective cohort studies, a diagnosis of an
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Achilles tendon disorder, and studies reporting at least one of the following outcomes: Time to
recover (or play), recurrences, patient-reported outcomes (PROMs), pain scales, adverse events,
or VISA score. Exclusion criteria were articles that were case series or case reports.
Madhi et al. (2020) included 5 RCTs , 4 prospective and 2 retrospective cohort studies in
this systematic review. These studies were chosen by the authors after they examined the studies
for the inclusion and exclusion criteria. From these 11 studies, 203 patients underwent PRP
injection with ultrasound guidance for treatment of Achilles tendinopathy. The primary outcome
used to assess the effectiveness of the PRP injection was the VISA-A questionnaire as well as an
ultrasound scan for the assessment of the tendon thickness pre- and post-treatment. Patient means
baseline VISA-A score was 41.2 which improved to 70.12 after treatment, the mean difference
between VISA-A score was 28.9 points which were substantial compared to other non-operative
care approaches. Many of the retrospective studies suggested an advantage of using PRP, the
higher level of evidence studies do not support a significant efficacy. The studies in this
systematic review did have multiple limitations. Some of the studies have been cohort-controlled
and non-randomised, and the randomised controlled trials were small sample sizes. This study
specifically recommends that future research should include larger sample sizes to produce more
consistent results.
Nauwelaers, Van Oost and Peers (2020) conducted a systematic review to establish the
existing evidence of PRP injections for chronic midsubstance Achilles tendinopathy on the
functional outcome, with a risk of bias assessment of each included study. Systematic guidelines
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were used to perform their search for articles using the following databases: Embase, the
Cochrane Library and Pubmed. Inclusion criteria included only clinical trials comparing PRP
injections with a placebo, additional to eccentric exercise training for individuals diagnosed with
midsubstance Achilles tendinopathy. Exclusion criteria included: no placebo group, animal
studies, articles without full text availability, Achilles tendon rupture, incomplete literature and if
the article was not in English. The initial search yielded 367 articles. After narrowing the search
based on the inclusion and exclusion criteria, the authors decided on only 4 articles that were
used for this systematic review.
Nauwelaers, Van Oost and Peers (2020) systematic review used four RCTs with 170
participants. The primary outcome was VISA-A score at 3, 6 and 12 months post-injection.
However, only two of the four studies reported any follow up at the one year mark. As a
secondary measure, tendon structure was assessed under ultrasound. VISA-A scores at 3, 6 and
12 months show no significant difference between the PRP group and placebo group. Three of
the four studies used imaging to address the tendon structure under ultrasound. One study
reported significant reduction in tendon thickness and vascularity using PRP, one described an
increased tendon thickness, and the third reported no difference in tendon structure. The
conclusion of this study was that PRP injection offers no additional value to eccentric exercise
training for the treatment of Achilles tendinopathy. Their recommendation is for larger high
quality randomised controlled trials to be done to appreciate the effectiveness of PRP injections
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better. They also recommend more research be done to understand whether PRP injections’ goals
are to improve tendon structure or pain.
Zhang et al. (2018) conducted a meta analysis with the intention of gathering all RCTs
pertaining to PRP and its effectiveness for treatment of Achilles tendinopathy. The three
questions they posed were: does PRP plus eccentric strength training result in (1) greater
improvements in VISA-A scores; (2) differences in tendon thickness; or (3) differences in color
Doppler activity compared with placebo (saline) injections plus eccentric strength training in
patients with chronic Achilles tendinopathy? A search for peer reviewed articles was done using
PubMed, Web of Science (SCI-E/SSCI/A&HCI), and EMBASE. Exclusion criteria included
studies related to tendon tears rather than tendinopathy; assessed muscle injuries, were
duplicates, related to ligament injuries, had surgical interventions, or did not use PRP. The studies
used were analyzed for the following: control type, treatment type and technique. All trials that
were used in the meta-analysis compared PRP injection and eccentric training with saline
injection and eccentric training for chronic Achilles tendinopathy.
Zhang et al. (2018) identified 146 studies in their initial search of the literature. After
review of the studies, the authors kept 4 RCTs to include in their meta-analysis. The main
evaluation tool for each study was the VISA-A questionnaire, while three other studies also
evaluated tendon thickness change. Color Doppler activity and other functional measures such as
pain and return to sports activity were also measured. The study found there was no difference
between the PRP and saline groups regarding the primary outcome of the VISA-A questionnaire.

25
They also noted that there was no difference between the PRP and saline groups in terms of
ultrasonographic evaluation of tendon thickness; the mean difference between the PRP and saline
groups in tendon thickness change was 0.2 mm. There was also no difference between the PRP
and saline groups in terms of color Doppler activity. Pain levels and return to sport had mixed
results between the RCTs in the meta-analysis. The authors concluded larger randomized trials
are needed to confirm these results, but until or unless a clear benefit has been demonstrated in
favor of the new treatment, they cannot recommend it for general use.
Level Ⅱ Evidence: Based on the Johns Hopkins Nursing Evidence-Based Practice
appraisal tool, there were four articles that fell into the category of Level Ⅱ evidence. These are
a combination of articles from sections A and B of the appraisal tool used. The articles are
summarized below starting with articles in section A with Level Ⅱ evidence, and moving to
articles in section B with Level Ⅱ evidence.
Section A:
Filardo et al. (2014) conducted a quasi experimental study to evaluate the therapeutic
effects of repeated injections of PRP, administered to promote the healing of chronic Achilles
tendinopathy. 27 patients (22 men, five women) were enrolled in the study. Seven of the patients
had bilateral chronic Achilles tendinopathy, so 34 tendons were evaluated in this study. Inclusion
criteria were: history (>three months) of exercise-associated pain, pain or tenderness on
palpation and imaging findings (MRI or Ultrasound) of degenerative changes in the Achilles’
tendon. The VISA-A score improved significantly. In detail, the baseline score of 49.9 increased
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to 62.9 at two months, with a further improvement at six months, and remained stable at four
and a half years. 89% of the patients returned to sport and 93% of the patients were satisfied and
would repeat the treatment if needed (Filardo, 2014). The treatment failed in three patients, one
of which was a bilateral case. One patient was treated with corticosteroid injection before the 6
months’ evaluation, thus eliminating the participant from further follow up. The other two
patients sought surgical intervention, roughly one year after the PRP treatment. The main
findings of the study are that patients treated with repeated PRP injections for Achilles
tendinopathy obtained overall good results. Clinical improvement was significantly slower in
patients with a higher pretreatment symptom level, and the return to sport was more difficult in
patients with a longer history of symptoms. The authors recognized the current study has major
limitations, such as the lack of a randomised control group and imaging evaluation. Further
recommendations would be to repeat this in a RCT with a larger sample size.
Mautner et al. (2013) performed a retrospective cross sectional survey on 180 individuals
who received ultrasound-guided PRP injections for tendinopathy refractory to conventional
treatments. The aim of the study was to determine whether ultrasound-guided PRP injections are
an effective treatment for chronic tendinopathies. The inclusion criteria for the study was
subjects men or women between the ages of 18 and 75 years old who have been diagnosed with
tendinopathy for longer than six months. The individuals also needed to have tried conventional
treatment and have not had any resolution. Conventional treatment included: oral medications,
physiotherapeutic modalities and eccentric exercise. Exclusion criteria included sensory or
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neurologic complaints affecting the specified region, coagulation disorder, platelet disorder,
pregnancy, or a major systemic illness such as diabetes mellitus, rheumatoid arthritis,
fibromyalgia, autoimmune disorder, or any other condition that required strict antiplatelet or
anticoagulation therapy.
The results of the study done by Mautner et al. (2013) showed that 82% of participants
recorded a moderate-to-complete resolution of symptoms. Of the 180 participants, 27 of them
were individuals diagnosed with Achilles tendinopathy specifically. 100% of the participants
who received the ultrasound-guided injection in the Achilles tendon reported moderate to
complete resolution of symptoms. The perceived change in the visual analog scale (VAS) was
-5.2; resulting in an average reduction of pain of 75%. However, there was no significant
difference found in the estimated change in VAS between the patients who answered the survey
at 1 year or less after the PRP procedure and those who answered more than 1 year after the
procedure. From a functional standpoint, 68% of patients reported no pain while performing
activities and minimal to no pain before or after activities. 85% of patients were satisfied with
the procedure, 13% were dissatisfied, and 2% were indifferent. The study noted their limitations
being a small response rate in the survey study (only 55%); there was no standardization to the
rehabilitation protocols and recall bias based on the nature of the retrospective study design. The
authors concluded PRP has a positive effect in patients diagnosed with refractory tendinopathy.
However, more rigorous studies are needed to confirm these findings.
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Ferrero et al. (2012) used a quasi experimental design study to evaluate the effectiveness
of ultrasound (US)-guided autologous PRP injections in patellar and Achilles tendinopathy. The
study included 30 Achilles tendons and 28 patellar tendons. Individuals in the Achilles tendon
group ranged in age from 20 to 61 years old. All participants were physically active, competing
in competitive or amateur sports. The inclusion criteria was: presence of patellar or Achilles
tendinopathy, pain during palpation of the tendon and during physical activity for at least three
months, and ultrasound or MRI evidence of tendon degeneration. All participants had undergone
some form of other treatment that had been unsuccessful. The exclusion criteria was: systemic
disease, antiplatelet therapy in progress, intake of NSAIDs less than five days before the
procedure, hemoglobin <11 g/dl and platelets <150.000/mmc. The participants underwent a
pre-treatment examination where they filled out the VISA-A or VISA-P. These results were used
as a baseline to be compared to after the PRP injection. Each participant underwent two PRP
injections roughly three weeks apart. In all patients, clinical evaluation was performed using
VISA-P or VISA-A questionnaires. US evaluation included patellar or Achilles tendon thickness,
presence/absence of hypoechoic areas and vascularity on power Doppler 20 days and six months
after the second PRP administration. At the 6-month follow-up, patients were also asked about
their overall satisfaction with the treatment using a semiquantitative scale (poor, good, excellent).
For the Achilles tendon participants, the 20-day follow up was completed for all tendons. Only
23 tendons (19 patients) were followed up with at the six month time. The VISA-A score showed
minimal (non-significant) improvement compared to baseline was observed at the 20-day
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follow-up and a significant improvement at the six month follow-up. Tendon thickness was not
significantly reduced at the 20-day follow-up compared to baseline. However, at the six month
follow-up this reduction was statistically significant. Participants who followed up on their
Achilles tendon injection at the six month mark rated their overall satisfaction with the treatment
as: excellent for 10 tendons, good for 11 tendons and poor in nine tendons. The authors of this
study concluded that the use of PRP treatment for Achilles tendinopathy is feasible as a
minimally invasive treatment option. The authors also recommend further RCTs performed on a
larger sample size be done to confirm and validate their results.
Section B:
Vannini et al. (2013) performed a systematic review on platelet-rich plasma (PRP)
injections for foot and ankle pathologies. Their aim was to systematically review the literature
available on the clinical application of PRP for the treatment of foot and ankle pathologies, as
well as to understand its best indication for clinical use. This article was included in the review
of the literature due to this systematic review including PRP injections for the Achilles tendon
injections as part of the foot and ankle pathology. Research was performed using PubMed. The
inclusion criteria included: (1) papers in the English language, (2) dealing with the clinical
application of PRP for the treatment of orthopedic-related conditions affecting the foot and ankle
district, (3) with a I to IV level of evidence, and (4) reporting clinical results. The exclusion
criteria were reviews in vitro and animal studies, and studies that included non orthopedic
conditions. The initial search yielded 194 papers. After careful review of the inclusion and
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exclusion criteria, the authors decided 14 papers were considered eligible for inclusion. The
authors then analyzed the references of the 14 papers, and three more papers were included. At
the end of the process, 17 papers fulfilled the selection criteria.
Of the 17 papers discussed in this systematic review, five of them looked at PRP
injections and their effectiveness for treating Achilles tendinopathy. Those studies included 1
RCT and 4 case series. All four case series studies showed similar results in that the VISA-A
scores of the patients who received PRP injections accompanied by eccentric exercise training
improved over time (each study follow-up bench mark was slightly different). All four studies
also found significant decrease in pain with concomitant functional recovery. However, the only
randomized double-blind controlled trial that reported no significant difference between PRP and
placebo directly contrasts with those results. At this time, the authors recognize the limitations of
their systematic review to be lack of randomized controlled trials (for all foot and ankle
pathologies; not specifically Achilles tendinopathy in regards to PRP injections), and lack of a
true understanding of PRP. At this time there is no clear clinical indication for whether or not
PRP injections should be used to treat foot and ankle pathologies (including Achilles
tendinopathy) and further research must be done.
Level Ⅲ Evidence: Based on the Johns Hopkins Nursing Evidence-Based Practice
appraisal tool, there were three articles that fell into the category of Level Ⅲ evidence. These are
a combination of articles from sections A and B of the appraisal tool used. The articles are
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summarized below starting with articles in section A with Level Ⅲ evidence, and moving to
articles in section B with Level Ⅲ evidence.
Section A:
Murawski et al. (2014) performed a retrospective preliminary analysis to evaluate a series
of patients undergoing a single platelet-rich plasma (PRP) injection for the treatment of chronic
midsubstance Achilles tendinopathy, in whom conservative treatment had failed. The study
included 32 patients who underwent a single PRP injection. The patient returned to the clinic at
two weeks, six weeks, three months and six months. The Foot and Ankle Outcome Score
(FAOS) questionnaire and Short Form 12 (SF-12) general health questionnaire were used to
determine effectiveness of the injection. The FAOS and SF-12 were answered by the patients at
the pre-injection evaluation as well as the six month follow up post injection. At the six month
follow up, 78% or 25 patients reported they were asymptomatic and were able to return to sport
and daily activity. The FAOS outcome score improved significantly from 51 points prior to the
injection to 87 points at final follow-up. The SF-12 score also improved from 68 points
preinjection to 91 points at follow-up and was statistically significant. The remaining 22% or 7
patients reported no improvement at the six month follow up, and ultimately went on to have
surgical intervention of the Achilles tendon. This study acknowledged their limitations to be:
lack of control group, limited follow up time, no cytological analyses of the PRP aliquots
injected, and inconsistent physical therapy protocols. Despite the limitations, the authors
concluded that with 78% of patients reporting improvement of pain and functional status, PRP
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can be considered as a therapeutic option for the conservative management of Achilles
tendinopathy.
Monto (2012) conducted a case series using 30 patients to determine its potential
long-term efficacy in treating chronic cases of Achilles tendinopathy in which traditional
nonoperative management has failed. All 30 patients had undergone a minimum of six months of
standard nonoperative treatment including rest, physical therapy, silicone heel lifts, CAM walker
bracing, cast immobilization, night splinting, and non-steroidal medication. The patients had an
average duration of symptoms of eight months prior to the PRP injection. The American
Orthopaedic Foot and Ankle Society (AOFAS) hindfoot scoring data and physical examinations
were completed on all patients immediately prior to PRP treatment. They were then repeated at
the one, two, three, six, twelve and twenty-four month marks following the PRP injection.
Patients also repeated MRI or ultrasound imaging studies to be compared to the pretreatment
findings. Pre injection AOFAS scores averaged 34, and 22 of 26 patients who played sports were
unable to participate due to their condition. Ten of the 22 employed patients were also unable to
work because of the severity of their symptoms. All patients completed either an MRI (18
patients) or ultrasound imaging (12 patients) prior to the PRP injection. Of the MRI patients, all
exhibited signs of significant Achilles swelling, four had tendon calcifications, and six displayed
partial Achilles tendon tears. The Ultrasound studies showed all patients had Achilles swelling
and only four demonstrated partial Achilles tears. All patients in this study were also instructed
in a home based eccentrically based exercise program but the majority of patients were
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noncompliant in doing this regularly. The results showed 27 of 30 were satisfied with the results
of the PRP treatment at six months. At the 24-month follow up, 28 of 30 patients were satisfied.
Two patients were clinically dissatisfied with their results at the six month follow up due to
persistent pain and left the study. Those two patients went on to have surgical repair of the
Achilles tendon. The author concluded that PRP can safely and effectively be used to treat severe
chronic Achilles tendinitis in patients who have failed to respond to traditional nonoperative
management techniques.
Section B:
DiMatteo, Filardo, and Marcacci (2014) conducted a systematic review to analyze the
available clinical evidence concerning the application of PRP in the treatment of patellar and
Achilles tendinopathy. The inclusion criteria was: clinical reports of any level of evidence,
written in the English language, on the use of PRP to treat Achilles and patellar tendinopathy and
had no time limitation. The exclusion criteria was: case reports, articles written in other
languages and reviews and articles that did not report clinical results. Twenty-two articles were
used in this systematic review. Nine articles were focused solely on patellar tendinopathy, nine
were focused solely on Achilles tendinopathy and four articles reported data on both patellar and
Achilles tendinopathies. Twelve articles were used to assess the effectiveness of PRP injections
for Achilles tendinopathy. In regards to those articles, the results were mixed. Only one of the
studies was a randomized controlled trial and it showed no significant improvement in the
VISA-A scores of the patients who had the PRP injection compared to the control group
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(placebo injection). However,the remaining 11 articles were case series, and each one of those
found significant improvement, in a variety of timeframes for the effectiveness of PRP injections
when used to treat Achilles tendinopathy. The authors of this systematic review concluded this
particular study is not conclusive when assessing whether or not PRP is an effective treatment for
individuals with Achilles tendinopathy.
Critique of Strengths and Weaknesses
The appraisal of the 16 articles above listed various strengths and weaknesses. One key
strength to the articles evaluated is that 13 of those articles used the VISA-A as their primary
outcome measure. The VISA-A has been determined as the gold standard outcome measurement
for assessing pain and function of the Achilles tendon. However, the questions are geared toward
a sport specific population. Many of these studies did not specify the activity levels of the
participants prior to giving them the VISA-A as the assessment tool. The same evaluation tool
allowed for consistency when assessing the effectiveness of PRP injections on chronic Achilles
tendinopathy. The major weakness of the articles as a whole was lack of adequate sample size.
The largest sample size was reported in Mautner et. al (2013) with 180 participants. However,
this study was a retrospective, cross-sectional survey with lack of a control group. Another
weakness to this review of the literature was the lack ofRCTs. There were only five RCTs, one of
which was a pilot study. More studies with larger sample sizes would help findings be of greater
significance.
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Summary
Sixteen research articles were critically reviewed to determine whether platelet
rich plasma (PRP) is an effective treatment option for the treatment of chronic Achilles
tendinopathy. All articles were categorized into a Level of Evidence of I, II, Ⅲ according to The
Johns Hopkins Nursing Evidence-Based Practice appraisal tool. The articles were assessed for
quality and represented levels of fair, good, and excellent again according to The John Hopkins
Nursing Evidence-Based Practice appraisal tool. Five of the sixteen articles acknowledged that
PRP injections are an effective treatment option for chronic Achilles tendinopathy. Six of the
sixteen articles determined that PRP injections are not effective for the treatment of Achilles
tendinopathy. Five of the sixteen articles were unsure of the results, and recommended larger
randomized controlled trials be done with adequate sample sizes to confirm or deny the findings.
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Chapter Ⅳ: Discussion, Implications & Conclusions
The purpose of this review is to determine if PRP injections are effective treatment
options for chronic Achilles tendinopathy. After a critical analysis was conducted, 16 articles
were reviewed in chapter three. Chapter four will address the question presented, discuss the
trends and gaps within the literature, analyze the literature in terms of implications in athletic
training, and provide recommendations for further research.
Literature Synthesis
The main focus of this Critical Review of the Literature was to answer the question, “Is
platelet rich plasma an effective treatment option for individuals diagnosed with chronic Achilles
tendinopathy?” Sixteen articles were reviewed to answer this question. The following paragraphs
will separate all 16 articles into three different categories: (1) PRP injections are effective for the
treatment of Achilles tendinopathy, (2) PRP injections are not effective for the treatment of
Achilles tendinopathy, and (3) no conclusions can be drawn regarding whether or not PRP is
effective for the treatment of Achilles tendinopathy.
Eight of the 16 articles used in this Review of the Literature concluded that PRP
injections were an acceptable and minimally invasive treatment option for Achilles tendinopathy.
Boesen et al. (2017) was the only article of “high quality” while the following four articles were
considered of “good” quality: Ferrero et al. (2012), Mautner et al. (2013), Filardo et al. (2014)
and Liu et al. (2019). Of these four articles, Liu et al. was the only Meta-Analysis which
analyzed five RCTs. The VISA-A was the primary outcome of all five RCTs. Of those five
RCTs, four followed up with the participants at six weeks, and five of the articles followed up
with participants at 6, 12 and 24 weeks. The results stated that there was no significant difference
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found in improvement; however, the PRP group’s VISA-A score was significantly higher than
the control group at the six-week mark. Liu et al. (2012) also found that the thickness of the
Achilles tendon was significantly thinner after the PRP injection. This can be an objective
measure as to why participants feel relief of symptoms of their Achilles tendinopathy. Mautner et
al. (2013) had the largest sample of Achilles tendons used in their study at 180 Achilles tendons.
This was a retrospective, cross sectional survey to determine participant satisfaction after
receiving a PRP injection to treat chronic tendinopathies. Prior to PRP injections, 180
participants underwent physical therapy that included eccentric exercise. Of the 180 participants,
27 of them were patients diagnosed with Achilles tendinopathy who all reported moderate to
complete resolution of symptoms. The study, as a whole, reported that 82% of patients
experienced significant improvement in symptoms and 68% of participants reported no pain
while performing activities and minimal to no pain before or after activities. Ferrero et al. (2012)
was the last article in the “good” category; this was a quasi-experimental study which looked at
30 Achilles tendons.
The remaining three articles which were supportive of using PRP injections to treat
Achilles tendinopathy were Di Matteo et al. (2014), Monto (2012) and Murawski (2014); these
articles fell into the “fair” category when ranking quality. Filardo et al. (2014), Ferrero et al.
(2012), Monto (2012), and Murawski (2014) were all very similar in their findings. At the sixth
month follow up, patients were reporting a decrease in symptoms, a return to sport and physical
activity, as well as reduction of tendon thickness and increased intratendinous vascularity. Di
Matteo et al. (2014) was a systematic review that included one RCT and 11 case series. Their
results were favorable to using PRP injections for the treatment of chronic Achilles tendinopathy.
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However, the favorable results came from the case series, and the RCT actually did not support
their conclusion.
Five of the 16 articles concluded that their results did not support the treatment of PRP
injections for individuals diagnosed with Achilles tendinopathy. There were no articles in the
“high quality” category, and four were categorized as “good”. De Vos et al. (2010) performed a
RCT in which 54 participants were divided into two groups. Twenty-seven participants
underwent the PRP injection while 27 received a placebo injection into the Achilles tendon. At
the six-month follow up, the VISA-A scores were not significantly different than the control
group. Jonge et al. (2011) followed up on the same participant pool at the one-year mark
following their injections. He found that both the PRP group and the placebo group had
improved VISA-A scores; however, there was no significant difference between the two groups.
The other two “good” quality articles were systematic reviews by Vannini et al. (2013) and
Nauwelaers et al. (2020). Vannini et al. (2013) looked at 17 studies, although only nine studies
evaluated the efficacy of PRP in the Achilles tendon; the other studies pertained to other foot and
ankle pathologies. Nauwelaers et al. (2020) only reviewed four RCT, two of which were De Vos
et al. (2010) and Jonge et al. (2011). Their results were similar in that they could not recommend
the use of PRP injections for the treatment of Achilles tendinopathy. The study conducted by
Zhang et al. (2018) was classified in the “fair” category and concluded PRP injections with
eccentric training did not improve VISA-A scores, reduce tendon thickness, or reduce color
Doppler activity in patients with chronic Achilles tendinopathy compared with saline injection.
Larger randomized trials are needed to confirm these results, but until or unless a clear benefit
has been demonstrated in favor of the new treatment, we cannot recommend it for general use.
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Lastly, there were three articles of the 16 that could not draw a specific conclusion for
whether or not PRP injections were effective for the treatment of Achilles tendinopathy. Those
studies included no “high” quality studies, two of “good” quality (Krogh (2016), and Madhi et al.
(2020)), and one “fair” quality article (Kearney 2013). Madhi et. al (2020), a systematic review
of literature, analyzed five randomised control trials, four prospective studies, and two
retrospective cohort studies. Although the results were inconclusive, many of the retrospective
studies suggested an advantage of using PRP; however, the higher level of evidence studies do
not support a significant efficacy. They recommended more RCTs with larger sample sizes be
conducted in order to confirm the results of the retrospective studies. Krogh (2016), a RCT with
24 patients, found no statistical significance in the difference in the primary outcome of the
VISA-A scores, but did find statistically significant secondary outcomes of color Doppler
activity and tendon thickness. They also reported a large drop-out rate after the three-month mark
and could not make long term comparisons. Lastly, Kearney et al. (2013), a pilot RCT, looked at
20 patients and found no statistical significance between the PRP group and the exercise only
group from the primary endpoint of six months. This, however, was an expected outcome based
on the nature of the pilot study, but demonstrated the methodology is feasible to perform a larger
RCT.
Current Trends and Gaps in Literature
During this Critical Review of the Literature, multiple trends and gaps were identified.
First, the number of RCTs conducted to determine the effectiveness of PRP injections for the
treatment of chronic Achilles tendinopathy is very limited. In this review, only four articles were
RCTs, and one other was a RCT pilot. As the gold standard for research, this shows there is a lot
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of potential for bias among the other studies that are currently available. Di Matteo et al. (2014)
performed a systematic review of the literature regarding the effectiveness of PRP on Achilles
tendinopathy. They found that 12 papers met the inclusion criteria; however, only one trial was a
double-blind RCT, whereas the others were all case series. Second, the sample sizes of the
studies found were small. Some of the studies which had larger sample sizes did not focus solely
on Achilles tendinopathy. For example, Vannini et al. (2013), a systematic review, took 17
studies and reviewed the effectiveness of PRP injections on foot and ankle pathologies. Only
nine of those studies dealt with Achilles tendinopathy.
In addition to the lack of RCT and small sample size, the standardization for the PRP
injections varied in each study. For example, two of the RCT had vastly different procedures for
administering the PRP injection. De Vos et al. (2010) collected 54 mL of blood from each of the
participants. The blood was then mixed with 6 mL of citrate to prevent clotting in the centrifuge.
The mixed sample was placed in the centrifuge and ran for 15 minutes. To match the pH of PRP
with the pH of the tendon tissue, the researchers added 0.3 mL of 8.4% sodium bicarbonate
buffer to the mixture. One milliliter of PRP was collected and analyzed for possible
contamination. They used a 22-gauge needle to inject 2 mL of a local anesthetic and 4 mL of the
PRP sample. The procedure was performed under ultrasound guidance to ensure proper
placement of the PRP. Post procedure, the participants were asked to be non-weight bearing for
four weeks and began a 12-week eccentric exercise program. Boesen et. al (2017)’s purpose was
to determine whether eccentric training, in combination with high-volume injection (HVI) or
PRP injections, would improve outcomes of participants with Achilles tendinopathy. Their
participants were divided into three groups: HVI, PRP or placebo. The participants in the PRP
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group had only 10 mL of blood drawn. The blood was spun in the centrifuge for five minutes and
approximately 4 mL of PRP sample was obtained. A 21-gauge needle was used under ultrasound
guidance to direct the injection. However, placement of the injection was dependent on the most
symptomatic area based on patient feedback and palpation. No local anesthetic was used, and the
procedure itself was performed four times with the first injection at baseline and with 2-week
intervals between each injection. Participants were able to bear weight immediately after the
injections and began a 12-week eccentric exercise program. The remaining studies also had
variations of how the PRP was prepared and injected. This can cause discrepancy in results,
altering whether or not PRP injections were, in fact, effective for the treatment of chronic
Achilles tendinopathy.
Implications for Athletic Training
Implications for athletic training, based on the findings of this Critical Review of the
Literature, include discussing and educating patients and healthcare providers about the potential
but also the uncertainty of the use of PRP injections for the treatment of chronic Achilles
tendinopathy. When discussing various treatment options for chronic Achilles tendinopathy, it is
critical to consider the research that has already been completed. This will allow for the patient
and the healthcare provider to choose a treatment option best suited for the patient. Athletic
trainers serve as advocates for their patients as well as licensed delegates of the physicians. This
allows them to have informational conversations with both parties to ensure the providers are
giving the best care and patients are receiving the best care. The findings of this review offer a
starting point for further research regarding the efficacy of PRP injections and the treatment of
chronic Achilles tendinopathy. With more research, it is hopeful a more comprehensive
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understanding of PRP can be developed. This would potentially lead to more evidence and better
practice standards in hopes that insurance companies would then cover PRP injections as
treatment options (Jones, 2018). Achilles tendinopathy is one of the most frequent ankle/foot
overuse injuries, and is characterized by a combination of pain, swelling, and impaired
performance (Li, 2016). The current gold standard treatment is eccentric exercise training
(O’Neill, 2015). However, not all individuals respond to that form a treatment. As more people
are affected each year, now is the time to continue the growing research on PRP injections and
determine whether or not they can be used safely and effectively for the treatment of chronic
Achilles tendinopathy.
Conclusion
The findings of this review did not completely validate that PRP injections are an
effective treatment option for individuals diagnosed with chronic Achilles tendinopathy. To come
to this conclusion, 16 articles were reviewed using the Bethel University Graduate Nursing
Program matrix format and were further evaluated with use of the John Hopkins Nursing
Evidence-Based appraisal tool. Eight articles were in favor of using PRP injections to treat
chronic Achilles tendinopathies, five articles reported PRP injections were not an effective
treatment option, and three articles concluded they required larger scale studies to make a
determination. Overall, the critical review of the literature provides vastly different evidence on
the effectiveness of PRP injections for treatment of chronic Achilles tendinopathy. Future
research should focus on completing large sample size RCTs with standardization of the
preparation/procedure of the PRP injection. With that information, PRP injections can be used
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secondary to traditional treatment of eccentric exercise and other modalities for patients who are
looking for a minimally invasive treatment option.
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Appendix A: Literature Review Matrix
Level Ⅰ Evidence; Section A
Source: Boesen, A., Hansen, R., Boesen, M., Malliaras, P., & Langberg, H. (2017). Effect of High-Volume Injection,
Platelet-Rich Plasma, and Sham Treatment in Chronic Midportion Achilles Tendinopathy: A Randomized Double-Blinded
Prospective Study. The American Journal of Sports Medicine, 45(9), 2034–2043. https://doi.org/10.1177/0363546517702862
Design Methodology/Purpose

Sample/Setting

Randomized controlled trial

A total of 60 men (age,
18-59 years) with
Purpose: To determine whether
chronic (>3 months) AT
eccentric training in combination
were included and
with high-volume injection (HVI) or followed for 6 months
platelet-rich plasma (PRP)
(n = 57).
injections improves outcomes in AT.
John Hopkins Evidence
Method: All participants performed Appraisal
eccentric training combined with
either (1) one HVI (steroid, saline,
Level: 1
and local anesthetic), (2) four PRP
injections each 14 days apart, or (3) Quality: A
placebo (a few drops of saline under
the skin). Randomization was
stratified for age, function, and
symptom severity (Victorian
Institute of Sports
Assessment–Achilles [VISA-A]).

Design Instruments

Results

Outcomes included function
and symptoms (VISA-A),
self-reported tendon pain
during activity (visual analog
pain scale [VAS]), tendon
thickness and intratendinous
vascularity (ultrasonographic
imaging and Doppler signal),
and muscle function (heel-rise
test). Outcomes were assessed
at baseline and at 6, 12, and 24
weeks of follow-up.

Treatment with HVI or PRP
in combination with
eccentric training in chronic
AT seems more effective in
reducing pain, improving
activity level, and reducing
tendon thickness and
intratendinous vascularity
than eccentric training alone.
HVI may be more effective
in improving outcomes of
chronic AT than PRP in the
short term

Recommendations: Larger sample size, determine the exact concentration of platelets and growth factors in the PRP

Source: de Vos RJ, Weir A, van Schie HTM, et al. Platelet-Rich Plasma Injection for Chronic Achilles Tendinopathy: A
Randomized Controlled Trial. JAMA. 2010;303(2):144–149. doi:10.1001/jama.2009.1986
Design Methodology/Purpose

Sample/Setting

Randomized Control Trial
54 randomized
Purpose: To examine whether a PRP
patients aged 18 to 70
injection would improve outcome in chronic years with chronic

Design Instruments

Results

All patients completed a
questionnaire consisting of
standardized outcome

The mean VISA-A
score improved
significantly after 24

49
midportion Achilles tendinopathy
Method: Stratified, block-randomized,
double-blind, placebo-controlled trial. The
PRP treatment was disseminated as a
potentially successful treatment for
tendinopathies. According to the study
protocol, the primary analysis was
performed after 24 weeks of follow-up.
After 24 weeks, blinding was disclosed for
the primary researcher. Results at 52 weeks
will be used as a secondary outcome to
describe the long-term results in a future
analysis.

tendinopathy 2 to 7
cm above the Achilles
tendon insertion
John Hopkins
Evidence Appraisal
Level: 1

measures at baseline and after
6, 12, and 24 weeks. The
primary outcome measure
VISA-A questionnaire.
Secondary outcome measures
were subjective patient
satisfaction, return to sports,
and adherence of the eccentric
exercises.

Quality: B

weeks in the PRP
group by 21.7 points
(95% confidence
interval [CI],
13.0-30.5) and in the
placebo group by 20.5
points (95% CI,
11.6-29.4). The
increase was not
significantly different
between both groups

Recommendations: No recommendations were given

Source: Jonge, S. D., Vos, R. J., Weir, A., Schie, H. T., Bierma-Zeinstra, S. M., Verhaar, J. A., . . . Tol, J. L. (2011). One-Year
Follow-up of Platelet-Rich Plasma Treatment in Chronic Achilles Tendinopathy. The American Journal of Sports Medicine,
39(8), 1623-1630. doi:10.1177/0363546511404877
Design Methodology/Purpose

Sample/Setting

Design Instruments

Results

A Double-Blind Randomized
Placebo-Controlled Trial
Purpose: To study the effects of a
platelet-rich plasma injection in
patients with chronic midportion
Achilles tendinopathy at 1-year
follow-up

54 patients aged
18-70 years
diagnosed with
chronic
tendinopathy

The primary outcome was the
VISA-A score. Other outcome
measures were subjective
patient satisfaction (scored as
moderate, poor, good, or
excellent) and return to sports
activity (scored as not active
in sports, no return to sports,
returning to sport but not in
desired sport, returning to
desired sport but not at the
preinjury level, or returning to
preinjury level in the desired
sport). Tendon structure was
evaluated quantitatively by
means of UTC (UTCimaging,
Stein, the Netherlands).
Neovascularization was
scored using the modified O¨
hberg scoring system.

The mean Victorian Institute of
Sports Assessment–Achilles score
improved in both the platelet-rich
plasma group and the placebo
group after 1 year. There was no
significant difference in increase
between both groups (adjusted
between-group difference, 5.5;
95% confidence interval, –4.9 to
15.8, P = .292). In both groups,
59% of the patients were satisfied
with the received treatment.
Ultrasonographic tendon structure
improved significantly in both
groups but was not significantly
different between groups (adjusted
between-group difference, 1.2%;
95% confidence interval, –4.1 to
6.6, P = .647).

Method: participants were
randomized to receive either a
blinded injection containing
platelet-rich plasma or saline
(placebo group) in addition to an
eccentric training program. The
main outcome was the validated
Victorian Institute of Sports
Assessment–Achilles score. Patient
satisfaction was recorded and
ultrasound examination performed
at baseline and follow-up.

John Hopkins
Evidence
Appraisal
Level: 1
Quality: B
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Recommendations: No recommendations were given

Source: Kearney, R. S., Parsons, N., & Costa, M. L. (2013). Achilles tendinopathy management: A pilot randomised controlled
trial comparing platelet-rich plasma injection with an eccentric loading programme. Bone & joint research, 2(10), 227–232.
https://doi.org/10.1302/2046-3758.210.2000200
Design Methodology/Purpose

Sample/Setting

Design Instruments

Results

A pilot randomised controlled trial
Purpose: To conduct a pilot
randomised controlled trial to evaluate
the feasibility of conducting a larger
trial to evaluate the difference in
Victorian Institute of Sports
Assessment-Achilles (VISA-A) scores
at six months between patients with
Achilles tendinopathy treated with a
platelet-rich plasma (PRP) injection
compared with an eccentric loading
programme.

20 participants who
were assessed at a
United Kingdom
teaching hospital

All patients were assessed at
standard clinical follow-up at
six weeks, three months and
six months. At these
timepoints the VISA-A
questionnaire was
administered, which was the
primary outcome measure.

The mean VISA-A score for
the injection group at the
primary endpoint of six
months was 76.0 (95%
confidence interval (CI)
58.3 to 93.7) and for the
exercise group was 57.4
(95% CI 38.1 to 76.7).
There was no statistically
significant difference
between these scores (p =
0.171)

John Hopkins
Evidence Appraisal
Level: 1
Quality: C

Method: Two groups of patients with
mid-substance Achilles tendinopathy
were randomised to receive a PRP
injection or an eccentric loading
programme. A total of 20 patients were
randomised, with a mean age of 49
years (35 to 66). All outcome measures
were recorded at baseline, six weeks,
three months and six months.
Recommendations: The results of this pilot trial would enable conclusions to be drawn regarding the feasibility of completing
a full study to evaluate the clinical effectiveness of PRP injections.

Source: Krogh, E. (2016). Ultrasound-Guided Injection Therapy of Achilles Tendinopathy With Platelet-Rich Plasma or Saline:
A Randomized, Blinded, Placebo-Controlled Trial. The American Journal of Sports Medicine, 44(8), 1990–1997.
https://doi.org/10.1177/0363546516647958
Design Methodology/Purpose

Sample/Setting

Design Instruments

Results
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RCT

24 patients

Purpose: To examine whether 1
injection of platelet-rich plasma
(PRP) would improve outcomes
more effectively than placebo
(saline) after 3 months in patients
with AT.

John Hopkins
Evidence Appraisal
Level: 1
Quality: B

Method: A total of 24 patients with
chronic AT (median disease
duration, 33 months) were
randomized (1:1) to receive either a
blinded injection of PRP (n = 12) or
saline (n = 12).

The primary endpoint was
improvement in Victorian
Institute of Sports
Assessment–Achilles
(VISA-A) score at 3 months.
Secondary outcomes were
pain at rest, pain while
walking, pain when the
tendon was squeezed,
ultrasonographic changes in
tendon thickness, and color
Doppler activity.

PRP injection did not result in an
improved VISA-A score over a
3-month period in patients with
chronic AT compared with
placebo. The only secondary
outcome demonstrating a
statistically significant difference
between the groups was change in
tendon thickness; this difference
indicates that a PRP injection
could increase tendon thickness
compared with saline injection.
The conclusions are limited to the
3 months after treatment owing to
the large dropout rate.

Recommendations: A larger study population could demonstrate statistically significant differences that were not revealed in
our study.

Level Ⅰ Evidence; Section B
Source: Liu, C. J., Yu, K. L., Bai, J. B., Tian, D. H., & Liu, G. L. (2019). Platelet-rich plasma injection for the treatment of
chronic Achilles tendinopathy: A meta-analysis. Medicine, 98(16), e15278. https://doi.org/10.1097/MD.0000000000015278
Design Methodology/Purpose

Sample/Setting

Design Instruments

Results

Meta-Analysis
Purpose: evaluated the current
evidence for the efficacy of PRP as
a treatment for chronic Achilles
Tendinopathy (AT).

5 RCTs were used
in this
Meta-Analysis

Outcome measurements included the
Victorian Institute of Sports
Assessment-Achilles (VISA-A), visual
analog scale (VAS) and Achilles tendon
thickness. Statistical analysis was
performed. Two independent reviewers
(CJL and JBB) evaluated the quality of
the included studies by using the ROB
tool provided by the Cochrane
collaboration. The mean difference and
95% CI were calculated and analysed as
the effect amounts in accordance with the
ankle function scores of each study
treatment group and control group. If
multiple ankle joint function scores were
used in the study, the priority sequence of
VISA-A, VAS, and Achilles tendon
thickness was calculated in case of

PRP injection around
the Achilles tendon is
an option for the
treatment of chronic
AT, but has limited
evidence.

Method: The PubMed, Embase,
Web of Science, and The Cochrane
Library databases were searched for
articles on randomized controlled
trials (RCTs) that compared the
efficacy of PRP with that of
placebo injections plus eccentric
training as treatment for AT.

John Hopkins
Evidence Appraisal
Level: 1
Quality: B
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complete data. Data extraction,
transformation and analysis methods were
performed in reference to the Cochrane
system evaluation manual.
Recommendations: These results still require verification by a large number of well designed, heterogeneous RCT studies

Source: Madhi, M. I., Yausep, O. E., Khamdan, K., & Trigkilidas, D. (2020). The use of PRP in treatment of Achilles
Tendinopathy: A systematic review of literature. Study design: Systematic review of literature. Annals of medicine and surgery
(2012), 55, 320–326. https://doi.org/10.1016/j.amsu.2020.04.042
Design Methodology/Purpose

Sample/Setting

Systematic Review
Purpose: to ascertain the efficacy of
Platelet Rich Plasma (PRP) as a
treatment option in chronic Achilles
tendinopathy.

5 Randomised control
trials, 4 prospective and
2 retrospective cohort
studies were included
in this systematic
review. A total number
Method: PRISMA reporting item
of 406 patients were
for systematic review has been used treated for
to conduct the selection, Electronic
non-insertional Achilles
databases included PubMed,
tendinopathy of which
EMBASE, Cochrane collaboration,
230 patients had PRP
Google scholar, the web of science
local injection under
and Cochrane Library were searched Ultrasound guide.
for all RCT, prospective and
retrospective studies conducted
between January 2010 to February
2019.
John Hopkins Evidence
Appraisal

Design Instruments

Results

The primary outcome was the
VISA-A score and Ultrasound
scan assessment of the tendon
thickness pre- and
post-treatment. Oxford CEBM
tool was used to assess the
articles for validity, relevance
and applicability of the results.
All studies were of high quality
and varied slightly in terms of
the blinding methods
implemented.

Many of the retrospective
studies suggested an
advantage of using PRP, the
higher level of evidence
studies do not support a
significant efficacy. This
systematic review showed
very promising results from
the use of Platelet Rich
Plasma demonstrated by a
significant improvement in
the VISA-A score

Level: 1
Quality: B
Recommendations: More RCTs with large sample size to determine treatment effectiveness

Source: Nauwelaers, A. K., Van Oost, L., & Peers, K. (2020). Evidence for the use of PRP in chronic midsubstance Achilles
tendinopathy: A systematic review with meta-analysis. Foot and ankle surgery : official journal of the European Society of Foot
and Ankle Surgeons, S1268-7731(20)30163-6. Advance online publication. https://doi.org/10.1016/j.fas.2020.07.009
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Design Methodology/Purpose

Sample/Setting

Design Instruments

Results

Systematic review with meta
analysis
Purpose: establish the existing
evidence of PRP injections for
chronic midsubstance AT on the
functional outcome, with a risk of
bias assessment of each included
study.

Clinical; 4 RCTs, 170
patients

comparison: saline injection or
placebo, outcome: VISA-A
and study design: clinical
trials.

Method: According to the PRISMA
guidelines systematic searches were
performed in Embase, the Cochrane
library and Pubmed on June 12,
2020 for relevant literature. Only
clinical trials comparing PRP
injections with placebo, additional
to an eccentric training program, in
midsubstance AT were included.
The primary outcome was Victorian
Institute of Sport Assessment Achilles (VISA-A) score at 3, 6 and
12 months post-injection. Risk of
bias was assessed using the
Cochrane risk-of-bias tool for
randomized trials (Rob 2). As
secondary outcome we assessed
reported changes in tendon structure
after PRP injections.

Quality: B

A total of 367 studies were
identified with the initial
database search. Finally, four
randomized controlled trials
(RCTs) met inclusion criteria
for systematic review and
meta-analysis with data of
170 patients available for
pooling. Results showed no
difference in clinical
outcome between the PRP
and placebo group at
different points in time using
the VISA-A score as
outcome parameter (3
months 0.23 (CI -0.45, 0.91);
6 months 0.83 (CI -0.26,
1.92); 12 months 0.83 (CI
-0.77, 2.44)).

John Hopkins Evidence
Appraisal
Level: 1

Recommendations: PRP has no clear additional value in management of chronic midsubstance Achilles tendinopathy and
therefore should not be used as a first-line treatment option.

Source: Zhang, Y. J., Xu, S. Z., Gu, P. C., Du, J. Y., Cai, Y. Z., Zhang, C., & Lin, X. J. (2018). Is Platelet-rich Plasma Injection
Effective for Chronic Achilles Tendinopathy? A Meta-analysis. Clinical orthopaedics and related research, 476(8), 1633–1641.
https://doi.org/10.1007/s11999.0000000000000258
Design Methodology/Purpose

Sample/Setting

Design Instruments

Results

Meta-Analysis
Purpose: to gather the Randomized
control trials (RCT) done regarding
PRP treatment on achilles

4 Level 1 RCT trials
with 170 participants
used in the quantitative
synthesis

The primary endpoint was
improvement in the VISA-A
score, which ranges from 0 to
100 points with higher scores

PRP injection with eccentric
training did not improve
VISA-A scores, reduce
tendon thickness, or reduce

54
tendinopathy and determine whether
or not the research says PRP is an
effective treatment option
John Hopkins Evidence
Appraisal
Method: A search of peer-reviewed
articles was conducted to identify
Level: 1
all RCTs using PRP injection with
eccentric training for chronic
Quality: C
Achilles tendinopathy in the
electronic databases of PubMed,
Web of Science
(SCI-E/SSCI/A&HCI), and
EMBASE from January 1981 to
August 2017. Two reviewers
assessed study quality using the
Cochrane Collaboration risk-of-bias
tool. The primary endpoint was
improvement in the VISA-A score

representing increased activity
and less pain. The VISA-A
score is a validated
questionnaire, specifically
designed for evaluating
outcome in Achilles
tendinopathy. Secondary
outcomes were tendon
thickness, color Doppler
activity, and other functional
measures (such as pain and
return to sports activity).

color Doppler activity in
patients with chronic
Achilles tendinopathy
compared with saline
injection. Larger randomized
trials are needed to confirm
these results, but until or
unless a clear benefit has
been demonstrated in favor
of the new treatment, we
cannot recommend it for
general use.

Recommendations: Larger randomized trials are needed to confirm these results

Level Ⅱ Evidence; Section A
Source: Filardo, G., Kon, E., Di Matteo, B., Di Martino, A., Tesei, G., Pelotti, P., Cenacchi, A., & Marcacci, M. (2014).
Platelet-rich plasma injections for the treatment of refractory Achilles tendinopathy: results at 4 years. Blood transfusion =
Trasfusione del sangue, 12(4), 533–540. https://doi.org/10.2450/2014.0289-13
Design Methodology/Purpose

Sample/Setting

Design Instruments

Results

Quasi-experimental
Purpose: document the mid-term
results obtained after treating
recalcitrant Achilles tendinopathy
with injections of high concentrate,
leucocyte-rich PRP

Clinical; 27 patients
enrolled--34 Achilles
tendons assessed (7
patients had bilateral
AT)
John Hopkins Evidence
Appraisal

Blanzina, VISA-A, EQ-VAS
for general health, and Tegner
scores

The VISA-A score showed a
significant improvement: the
baseline score of 49.9±18.1
increased to 62.9±19.8 at 2
months (p=0.002), with a
further improvement at 6
months (84.3±17.1,
p<0.0005), and stable results
at 4.5 years (90.0±13.9). The
EQ-VAS score also showed
a similar positive trend. An
evaluation of the activity
level confirmed these
findings, showing a
significant improvement in

Method: Twenty-seven patients
(mean age: 44.6 years; 22 men and
5 women) affected by chronic
mid-portion Achilles tendinopathy
(7 bilateral, for a total of 34
tendons), refractory to previous
treatments, were enrolled. Patients
were treated with three

Level: 2
Quality: B
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ultrasound-guided intra-tendinous
injections of PRP at 2-week
intervals. Patients were
prospectively evaluated at baseline,
and then at 2, 6, and up to a mean of
54.1 months of follow-up
(minimum 30 months)

the Tegner score over time
(p=0.017 for the final
evaluation). The longer
duration of symptoms before
treatment was associated
with a slower return to sport
(p=0.041).

Recommendations: PRP injections produced good overall results for the treatment of chronic recalcitrant Achilles
tendinopathy with a stable outcome up to a medium-term follow-up. Longer symptom duration was related with a more difficult
return to sporting activity.

Source: Mautner, K., Colberg, R. E., Malanga, G., Borg-Stein, J. P., Harmon, K. G., Dharamsi, A. S., Chu, S., & Homer, P.
(2013). Outcomes after ultrasound-guided platelet-rich plasma injections for chronic tendinopathy: a multicenter, retrospective
review. PM & R : the journal of injury, function, and rehabilitation, 5(3), 169–175. https://doi.org/10.1016/j.pmrj.2012.12.010
Design Methodology/Purpose

Sample/Setting

Design Instruments

Results

A retrospective, cross-sectional
survey

Four academic sports
medicine centers from
across the United
States. A total of 180
men and women
between the ages of 18
and 75 years who
received
ultrasound-guided PRP
injections for
tendinopathy refractory
to conventional
treatments.

Survey on satisfaction and
functional outcome.Perceived
improvement in symptoms at
least 6 months after treatment,
perceived change in visual
analog scale score, assessment
of functional pain, and overall
satisfaction.

Overall, 82% of patients
indicated moderate to
complete improvement in
symptoms. The most
common injection sites were
the lateral epicondyle,
Achilles, and patellar
tendons. In this retrospective
study, in which we evaluated
administration of PRP for
chronic tendinopathy, we
found that the majority of
patients reported a moderate
(50%) improvement in pain
symptoms. The Achilles
tendon group had the best
response, with all
patients having at least
moderate improvement and
96% of patients reporting
mostly to complete
improvement. This finding
was promising for patients
with recalcitrant Achilles
tendinopathy because the
authors of one systematic

Purpose: To determine whether
ultrasound-guided platelet-rich
plasma (PRP) injections are an effective treatment for
chronic tendinopathies.
Method: The tendinopathy had to
be reconfirmed at the time of the
procedure with ultrasound
evaluation of the tendon after the
aforementioned criteria were met.
Patients must have received one or
more ultrasound-guided PRP
injections no less than 6 months
before the time of contact for the
survey. In addition, the procedure
must have followed a defined
protocol for preparation and
delivery of the PRP that included 2
patient identifiers, aseptic
technique, blood draw volume from
20-60 mL depending on
the amount of final PRP product

John Hopkins Evidence
Appraisal
Level: 2
Quality: B
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needed to inject into a specific
tendon, PRP preparation according
to manufacturer- recommendations,
no activator added, and ultrasound
guidance for the injection. Finally,
the patients must have
completed a rehabilitation program
that included eccentric
exercises no earlier than 4 weeks
after the procedure. The primary
outcome measurement
(improvement in symptoms) was
analyzed by calculating a global
average for all tendons, average
improvement for each of the most
commonly treated tendon groups,
and average improvement according
to the number of injections received.
The perceived change in VAS was
analyzed using a t-test for statistical
significance. Averages also were
calculated for functional
pain after PRP and overall
satisfaction with the procedure.

review noted that
24%-45.5% of patients with
Achilles tendinopathy
eventually consider surgery

Recommendations: PRP should be reserved for recalcitrant cases that do not respond to conservative treatments, including
eccentric exercises.

Source: Ferrero, G., Fabbro, E., Orlandi, D., Martini, C., Lacelli, F., Serafini, G., Silvestri, E., & Sconfienza, L. M. (2012).
Ultrasound-guided injection of platelet-rich plasma in chronic Achilles and patellar tendinopathy. Journal of ultrasound, 15(4),
260–266. https://doi.org/10.1016/j.jus.2012.09.006
Design Methodology/Purpose

Sample/Setting

Design Instruments

Results

quasi-experimental

30 Achilles tendons in
24 patients (16 men, 8
women) were
prospectively evaluated

VISA-A, Doppler to assess
tendon thickness

20 days after PRP injection
the patients presented a
non-significant improvement
of clinical symptoms. At the
6-month follow-up VISA
score increased from a mean
value of 57–75.5 (p < .01).
US evaluation revealed a
reduction of hypoechoic
areas in 26 tendons (p < .01)

Purpose: evaluate the effectiveness
of ultrasound (US)-guided
autologous PRP injections in
patellar and Achilles tendinopathy.
Method: Autologous PRP was
injected under US-guidance into the
Achilles and patellar tendons (30

John Hopkins Evidence
Appraisal
Level: 2

57
Achilles tendons, 28 patellar
tendons) in 48 prospectively
selected patients (30 males, 18
females, mean age 38 ± 16 years,
range 20–61 years). All patients
were previously evaluated
according to the Victoria Institute of
Sport Assessment (VISA) scale,
which assessed pain and activity
level, and they all underwent US of
the tendon before treatment and at
follow-up after 20 days and 6
months. Statistical analysis was
performed with Chi-square and
Wilcoxon tests.

Quality: B

associated with a widespread
improvement of fibrillar
echotexture of the tendon
and reduced
hypervascularity at power
Doppler. At the 6-month
follow-up, overall
satisfaction was rated by
patients in whom Achilles
tendon was treated as
positive in 21 tendons (70%;
excellent = 10/30 tendons;
good = 11/30 tendons) and
poor in 9 tendons (30%).

Recommendations: The present study shows that US-guided treatment of jumper's knee and Achilles tendinopathy using PRP
is feasible as it is an effective and minimally invasive treatment option. Further randomized controlled studies performed on a
larger sample size are warranted to confirm these preliminary results.

Level Ⅱ Evidence; Section B
Source: Vannini, F., Di Matteo, B., Filardo, G., Kon, E., Marcacci, M., & Giannini, S. (2014). Platelet-rich plasma for foot and
ankle pathologies: a systematic review. Foot and ankle surgery : official journal of the European Society of Foot and Ankle
Surgeons, 20(1), 2–9. https://doi.org/10.1016/j.fas.2013.08.001
Design Methodology/Purpose

Sample/Setting

Design Instruments

Results

A systematic Review

17 studies

Purpose: The aim of this article is
to systematically review all the
literature available on the clinical
application of PRP for the treatment
of foot and ankle pathologies, to
understand its potential and best
indications for clinical use.

John Hopkins Evidence
Appraisal

Achilles tendinopathy section
only: Victorian Institute of
Sport Assessment-Achilles
tendon (VISA-A)
questionnaire, and registering
patient satisfaction and return
to sport, Foot and Ankle
Ability Measure (FAAM),
Foot and Ankle Ability
Measure Sport (FAAM-S) and
Short Form Health Survey
(SF-8), AOFAS score
(depending on the study)

A total of 17 studies fulfilled
the inclusion criteria. Nine
papers dealt with Achilles
tendon management, 2
articles with plantar fasciitis,
3 papers with talar
osteochondral lesions, 2 with
PRP application in total
ankle replacement, and 1
article with PRP in foot and
ankle fusions. The overall
evaluation of the results
reported does not clearly
demonstrate the potential of
PRP treatment in any of the
specific fields of application.

Method: A systematic search of the
PubMed database was performed.
Research criteria were the
following: (1) papers in the English
language, (2) dealing with the
clinical application of PRP for the

Level: 2
Quality: B
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treatment of orthopedic-related
conditions affecting the foot and
ankle district, (3) with I to IV level
of evidence, and (4) reporting
clinical results.
Recommendations: it is important to underline that, at the present moment, it is impossible to define a clear indication for the
use of this biological product, neither as a conservative approach nor as a biological enhancer during surgical procedures. The
reasons for this lack of clinical evidence might be both the nature of PRP itself and the quality of the studies published up to the
present date.

Level Ⅲ Evidence; Section A
Source: Murawski, S. (2014). A Single Platelet-Rich Plasma Injection for Chronic Midsubstance Achilles Tendinopathy: A
Retrospective Preliminary Analysis. Foot and Ankle Specialist, 7(5), 372–376. https://doi.org/10.1177/1938640014532129
Design Methodology/Purpose

Sample/Setting

Design Instruments

Results

A Retrospective Preliminary Analysis

32 patients--mean
age of 41 years old

Foot and Ankle Outcome
Score and Short Form 12
general health
questionnaire; as well as
the patients’ ability to
return to athletic activity.

Twenty-five of 32 patients (78%)
reported that they were
asymptomatic at the 6-month
follow-up visit and were able to
participate in their respective
sports and daily activities. The
remaining 7 patients (22%) who
reported symptoms that did not
improve after 6 months
ultimately required surgery. Four
patients went on to have an
Achilles tendoscopy, while the
other 3 had an open debridement
via a tendon splitting approach.
A retrospective evaluation of
patients receiving a single PRP
injection for chronic
midsubstance Achilles
tendinopathy revealed that 78%
had experienced clinical
improvement and had avoided
surgical intervention at 6-month
follow-up.

Purpose: evaluate a series of patients
undergoing a single platelet-rich plasma
(PRP) injection for the treatment of
chronic midsubstance Achilles
tendinopathy, in whom conservative
treatment had failed.
Method: Thirty-two patients underwent
a single PRP injection for the treatment
of chronic midsubstance Achilles
tendinopathy and were evaluated at a
6-month final follow-up using the Foot
and Ankle Outcome Score and Short
Form 12 general health questionnaire.
Magnetic resonance imaging was
performed on all patients prior to and 6
months after injection.

John Hopkins
Evidence Appraisal
Level: 3
Quality: C

Recommendations: No recommendations were given by the authors

59
Source: Monto, R. (2012). Platelet Rich Plasma Treatment for Chronic Achilles Tendinosis. Foot & Ankle International, 33(5),
379–385. https://doi.org/10.3113/FAI.2012.0379
Design Methodology/Purpose

Sample/Setting

Design Instruments

Results

Case Series

30 patients--clinical
setting

AOFAS scoring was
completed for all patients
pretreatment and at 0, 1, 2, 3,
6, 12, and 24 months
post-treatment. MRI and/or
ultrasound studies were
completed for all patients
pre-treatment and at 6 months
post-treatment.

The average AOFAS score
increased from 34 (range, 20
to 60) to 92 (range, 87 to
100) by 3 months after PRP
treatment and remained
elevated at 88 (range, 76 to
100) at 24 months
post-treatment. Pretreatment
imaging abnormalities
present in the Achilles
tendon on MRI and
ultrasound studies resolved
in 27 of 29 patients at 6
months post-treatment.
Clinical success was
achieved in 28 of 30
patients.

Purpose: to determine its potential
long-term efficacy in treating
chronic cases of Achilles tendinosis
resistant to traditional nonoperative
management

John Hopkins Evidence
Appraisal
Level: 3

Method: Thirty patients with
chronic Achilles tendinosis who did
not respond to a minimum of 6
months of traditional nonoperative
treatment modalities were treated
with a single ultrasound guided
injection of PRP

Quality: C

Recommendations: No formal recommendations listed

Level Ⅲ Evidence; Section B
Source: Di Matteo, B., Filardo, G., Kon, E., & Marcacci, M. (2014). Platelet-rich plasma: evidence for the treatment of patellar
and Achilles tendinopathy—a systematic review. Musculoskeletal Surgery, 99(1), 1–9.
https://doi.org/10.1007/s12306-014-0340-1
Design Methodology/Purpose

Sample/Setting

Design Instruments

Results

A Systematic Review

Twelve papers in
total met the
inclusion criteria
and were analyzed.
Only one trial was
a double-blind
RCT, whereas the
others were all case
series.

VISA-A
questionnaire

The double-blind RCT was published
by de Vos et al. in 2010 and was
followed by a second paper dealing
with the same patients evaluated at
longer follow-up (1 year). The authors
compared PRP versus saline
injections in patients affected by
chronic mid-portion Achilles
tendinopathy for more than 2 months.
Fifty-four patients, aged from 18 to 70

Purpose: review systematically the
available clinical evidence concerning
the application of PRP in the treatment
of patellar and Achilles tendinopathy
Method: Articles were found using
PubMed. First, the articles were
screened by title and abstract. The

60
following inclusion criteria for relevant
articles were used during the initial
screening of titles and abstracts: clinical
reports of any level of evidence, written
in the English language, with no time
limitation, on the use of PRP to treat
conservatively Achilles and patellar
tendinopathy. Studies reporting the
application of PRP as a biological
augmentation during patellar and
Achilles surgical repair were excluded
from analysis. Other exclusion criteria
were as follows: case reports, articles
written in other languages and reviews.
In the second step, the full texts of the
selected articles were screened, with
further exclusions according to the
previously described criteria. Moreover,
articles not reporting clinical results
were excluded.

John Hopkins
Evidence Appraisal
Level: 3
Quality: C

years, were included and treated by a
single injection by needling technique
of either 4 mL of non-activated PRP
or 4 mL of saline solution. After the
injection, patients were assigned to a
standardized rehabilitation program
based on eccentric exercises.
Prospective evaluations were
performed for up to 24 weeks using
the VISA-A questionnaire, patient
satisfaction and return to sport. The
results showed improvements in both
treatment groups without any
significant inter-group difference in
any parameter considered. In a later
article, the authors reported the results
at 1 year of follow-up where they
confirmed no difference in clinical
outcome or in time to return to sport.

Recommendations: The most controversial debate concerns Achilles tendinopathy, since the only double-blind RCT showed
negative results for PRP, whereas the remaining trials (all case series) reported overall positive outcomes even at mid-/long-term
evaluation. In conclusion, the clinical data available, although not univocal, suggest considering PRP as an option for the
management of both patellar and Achilles tendinopathies.
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Appendix B: Quality Assessment
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